T-REXX isn't selling West Texas Intermediate crude in State College, PA. No friends, what we have here is a stinky dry gas from the Marcellus that doesn't even fetch 1/2 of the national average price. Dilutive options peel offs are Not open market purchases of stock with after tax dollars, dolt.
Exxon overpaid BIILIONs for Cross Timbers years and years ago. The founder of CHK drove his sports car into a stationary object at 80mph, and Halcon just posted a staggering loss and is working on 'balance sheet initiatives'. Any other brilliant suitors.....sparky ?
Wheat farmers in the Texas and Oklahoma panhandles circa 1928 to 1933 were faced with increasingly LOWER wheat prices. Their solution ? Plow more fields and grow more wheat. Guess what ? Prices kept going Down, and as a nasty side effect....dust bowl conditions. Companies like T-REXX have a noose around their throats.....excessive debt. So they drill, deplete, and pray. I seriously doubt your $3 MCF hedging comment for this basin.
Why don't you scream from the roof top that Genworth is trading for 1/10 of book value ?
Word has it that Value Stocks are about to enter a multi year bull move.
$2 BILLION per year in FREE cash flow per Street site article.
Bausch & Lomb!
This means you now have another competitor using Equity (not debt) to acquire Marcellus for less than $1 MCF. REXX is trapped. The DEBT is due, granted, you pushed off the due dates. Even terrible deep winters will not save REXX. There is simply an abundance of natural gas SUPPLY in the Marcelllus
Marcellus could be trading at 13 lucky cents per MCF by 2022. Marcellus = MASSIVE supply. Plenty more even lower....in the UTICA. LOL
Our team discounted the Free Cash Flow of the US Ten Year Treasury rate = $104.71.
REXX will plunge again and again because you have 3/4 of a BILLION dollars in DEBT and Marcellus natural gas frequently trades well below $1 MCF. Winter didn't save REXX.
VRX has plenty of warts and explaining to do. In the mean time....Bausch & Lomb marches on, as do sales of Provenge. The average nut wing on this message board cannot read a balance sheet, and doesn't take the time to understand pharma sales and products already in place.
Why not tape the Wall Street Journal stock pages to a board and let a monkey throw darts at it....to pick stocks ? Random is better than....professional ?
Ackman wouldn't climb into the Titanic. VRX has viable prospects ?
....to drive price of stock into the dirt, then scoop up shares?
$30 billion in debt is not due next week, it's called Long Term Debt.
Toe nail fungus can only do so much, other products generic already or will be soon ?
And why does my team believe the side effects of Jublia wont be recognized for years ?